Keynote Speaker
Benjamin O'Donnell, MD
Assistant Professor
Division of Endocrinology, Diabetes, and Metabolism
Medical Director, Medical Weight Management
The Ohio State University
Moderator
Amy Zack, MD
Case Western Reserve University
Objectives:
-
Describe the epidemiology of obesity and its intersection with diabetes.
-
Understand the role of glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) for diabetes and weight loss.
-
Prescribe effective and necessary lifestyle modifications as an accompaniment to pharmacological therapy.
Note: CME is not offered for viewing of the recording.
Download the presentation slides
If you have any questions, please contact the Cardi-OH Team at info@Cardi-OH.org.
If you share or use these presentations, or any parts thereof, please ensure you always credit the Ohio Cardiovascular and Diabetes Health Collaborative (Cardi-OH) AND you must provide a link to Cardi-OH.org.
